Singular Genomics Systems Inc (OMIC)
22.15
+0.25
(+1.14%)
USD |
NASDAQ |
Nov 22, 15:19
Singular Genomics Systems Shareholders Equity (Quarterly): 123.25M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 123.25M |
| June 30, 2024 | 137.71M |
| March 31, 2024 | 156.70M |
| December 31, 2023 | 179.01M |
| September 30, 2023 | 199.03M |
| June 30, 2023 | 218.39M |
| March 31, 2023 | 240.32M |
| December 31, 2022 | 260.32M |
| Date | Value |
|---|---|
| September 30, 2022 | 276.92M |
| June 30, 2022 | 297.56M |
| March 31, 2022 | 317.48M |
| December 31, 2021 | 336.17M |
| September 30, 2021 | 352.07M |
| June 30, 2021 | 366.58M |
| March 31, 2021 | -73.34M |
| December 31, 2020 | -51.56M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-73.34M
Minimum
Mar 2021
366.58M
Maximum
Jun 2021
208.54M
Average
229.36M
Median
Shareholders Equity (Quarterly) Benchmarks
| Bruker Corp | 1.807B |
| Azenta Inc | 1.769B |
| Harvard Bioscience Inc | 65.32M |
| Bionano Genomics Inc | 48.87M |
| Akoya Biosciences Inc | 13.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 186.55M |
| Total Liabilities (Quarterly) | 63.30M |
| Debt to Equity Ratio | 0.0419 |
| Current Ratio | 7.372 |
| Net Debt Paydown Yield | 2.53% |